Corbus Pharmaceuticals  Inc. logo

Corbus Pharmaceuticals Inc.

CRBP | NASDAQ
Chart Builder DCF Calculator
$7.79
+$0.14 (+1.83%)
Sep 22, 2026, 1:33 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
28.49M 17.2M 13.72M 17M 25.01M 85.43M
Short-Term Investments
134.78M 131.86M 7.18M 42.19M 72.64M n/a
Long-Term Investments
n/a n/a n/a n/a n/a 669.9K
Other Long-Term Assets
n/a 385K 690K 632.77K 523.81K 234.04K
Receivables
1.5M n/a n/a n/a n/a 2.58M
Inventory
n/a n/a n/a n/a n/a 350K
Other Current Assets
1.52M 3.91M 192K 192.48K 192.48K n/a
Total Current Assets
166.95M 152.98M 23.55M 60.18M 100.2M 92.07M
Property-Plant & Equipment
1.24M 2.52M 4.04M 5.5M 7M 9.32M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.24M 2.9M 4.73M 6.13M 7.53M 10.22M
Total Assets
168.2M 155.88M 28.27M 66.31M 107.73M 102.29M
Account Payables
2.22M 4.79M 3.18M 2.17M 1.78M 7.38M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a 16.21M 3.15M 3.86M 710.16K
Other Current Liabilities
2.86M 2.28M 39K 36.87K 133.71K 797K
Total Current Liabilities
20.69M 11.82M 31.89M 12.64M 17.01M 31.9M
Long-Term Debt
n/a n/a n/a 15.98M 15.64M 18.03M
Other Long-Term Liabilities
n/a n/a 44K 22.21K 22.21K n/a
Total Long-Term Liabilities
n/a 1.63M 3.28M 20.68M 21.61M 25.12M
Total Liabilities
20.69M 13.45M 35.18M 33.32M 38.62M 57.02M
Total Debt
1.63M 3.24M 20.89M 25.09M 26.59M 26.84M
Book Value
147.5M 142.43M -6.91M 32.99M 69.11M 45.27M
Book Value Per Share
11.08 13.05 -1.60 7.91 16.86 17.38
Common Stock
2K 1K n/a 417 12.52K 9.89K
Retained Earnings
-555.43M -476.89M -436.68M -392.08M -349.73M -304.09M
Comprehensive Income
-53K 35K -1K -126.09K -62.45K n/a
Shareholders Equity
147.5M 142.43M -6.91M 32.99M 69.11M 45.27M
Total Investments
134.78M 131.86M 7.18M 42.19M 72.64M 669.9K

© 2026 bestshares.com. All rights reserved.